O-SUBSTITUTED-DIBENZYL UREA-DERIVATIVES AS TRPV1 RECEPTOR ANTAGONISTS

Preparation of nucleosides as adenosine A3 receptor agonists

SULFONAMIDO COMPOUNDS THAT ANTAGONISE THE VANILLOID TRPV1 RECEPTOR

Preparation of N-aryl biarylcarboxamides as vanilloid-1 receptor modulators.

Preparation of O-substituted-dibenzyl urea derivatives as TRPV1 receptor antagonists.

Preparation of fused purine derivatives as adenosine A3 receptor modulators.

Preparation of O-substituted-dibenzyl (thio)urea derivatives as TRPV1 receptor antagonists.

Preparation of isoquinolinyl cyclohexenylacrylamides as transient receptor potential vanilloid 1 (TRPV1) receptor antagonists

Preparation of substituted purinylpyrazolylacetamides as adenosine A2B receptor antagonists.

Enhancing treatment of cancer and HIF-1-mediated disorders with adenosine A3 receptor antagonists.

Preparation of adenosine a2b receptor agonists for use as prodrugs treating diseases in mammals

SULFONAMIDO COMPOUNDS THAT ANTAGONISE THE VANILLOID TRPV1 RECEPTOR

Preparation of fused purine derivatives as adenosine A3 receptor modulators.

Preparation of sulfamoylphenyl thiourea derivatives as vanilloid TRPV1 receptor antagonists for the treatment of inflammatory states.

Enhancing treatment of HIF-1-mediated disorders with adenosine A3 receptor agonists.

Preparation of benzylthiourea derivatives as vanilloid TRPV1 receptor antagonists.

Preparation of sulfonamido nucleosides as human adenosine A3 receptro agonists and antitumor agents.

Method of diagnosing and treating Huntington's disease

Method for the diagnosis of heart diseases